{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T09:21:39Z","timestamp":1765963299266,"version":"3.48.0"},"reference-count":23,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T00:00:00Z","timestamp":1765929600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Oncology"],"abstract":"<jats:p>Purpose: ATRIP (ATR-interacting protein) is a critical partner of ATR (ataxia telangiectasia and Rad3-related). The ATR-ATRIP heterodimer plays an essential role in initiating homologous recombination repair (HRR) during replication stress and inducing double-stranded DNA breaks following unresolved stalled replication forks. Our team recently identified ATRIP as a novel breast cancer susceptibility gene candidate through whole-exome sequencing (WES) of familial breast cancer patients and healthy controls from the Polish founder population, with subsequent validation in both Polish and British cohorts. In the present study, we report for the first time the detection of a novel deleterious mutation in ATRIP among several members of an Iranian family with clustering of breast cancer who were negative for mutations in the already known breast cancer risk genes. Methods: Six family members underwent germline DNA testing by WES, following initial negative results from multigene panel testing. Candidate variants were confirmed by Sanger sequencing and assessed according to ACMG guidelines. Results: We detected a novel ATRIP frameshift mutation (NM_130384.3:c.1033delC) in four of six family members that were tested, including two individuals affected with breast cancer. No pathogenic variants were found in other known cancer susceptibility genes. Conclusions: This is the first report of a deleterious ATRIP mutation in an Iranian family with familial breast cancer, suggesting a potential role of ATRIP in hereditary breast cancer. Further studies are required to confirm the role of ATRIP in breast cancer susceptibility, refine risk assessment, and evaluate potential personalized therapeutic strategies. In the interim, genetic counseling for ATRIP mutation carriers should proceed with caution, given current limitations in clinical interpretation.<\/jats:p>","DOI":"10.3390\/curroncol32120711","type":"journal-article","created":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T08:32:27Z","timestamp":1765960347000},"page":"711","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A Novel ATRIP Mutation Detected in an Iranian Family with Familial Clustering of Breast Cancer: A Case Report"],"prefix":"10.3390","volume":"32","author":[{"given":"Neda","family":"Zamani","sequence":"first","affiliation":[{"name":"Women\u2019s College Research Institute, Women\u2019s College Hospital, University of Toronto, Toronto, ON M5S 1B2, Canada"},{"name":"Institute of Medical Science, Faculty of Medicine, University of Toronto, Toronto, ON M5S 3H2, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehar","family":"Chahal","sequence":"additional","affiliation":[{"name":"Women\u2019s College Research Institute, Women\u2019s College Hospital, University of Toronto, Toronto, ON M5S 1B2, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iman","family":"Salahshourifar","sequence":"additional","affiliation":[{"name":"Department of Biology, Science and Research Branch, Islamic Azad University, Tehran 1477893855, Iran"},{"name":"Farda Pathobiology & Genetic Laboratory, Tehran 1953774641, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reiyhane","family":"Talebian","sequence":"additional","affiliation":[{"name":"Farda Pathobiology & Genetic Laboratory, Tehran 1953774641, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad R.","family":"Akbari","sequence":"additional","affiliation":[{"name":"Women\u2019s College Research Institute, Women\u2019s College Hospital, University of Toronto, Toronto, ON M5S 1B2, Canada"},{"name":"Institute of Medical Science, Faculty of Medicine, University of Toronto, Toronto, ON M5S 3H2, Canada"},{"name":"Dalla Lana School of Public Health, University of Toronto, Toronto, ON M5T 3M7, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,12,17]]},"reference":[{"key":"ref_1","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1200\/JCO.2015.65.0747","article-title":"Frequency of Germline Mutations in 25 Cancer Susceptibility Genes in a Sequential Series of Patients With Breast Cancer","volume":"34","author":"Tung","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/nrc1431","article-title":"BRCA1 and BRCA2: 1994 and beyond","volume":"4","author":"Narod","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Breast Cancer Association Consortium, Dorling, L., Carvalho, S., Allen, J., Gonz\u00e1lez-Neira, A., Luccarini, C., Wahlstr\u00f6m, C., Pooley, K.A., Parsons, M.T., and Fortuno, C. (2021). Breast Cancer Risk Genes\u2014Association Analysis in More than 113,000 Women. N. Engl. J. Med., 384, 428\u2013439.","DOI":"10.1056\/NEJMoa1913948"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1056\/NEJMoa2005936","article-title":"A Population-Based Study of Genes Previously Implicated in Breast Cancer","volume":"384","author":"Hu","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1126\/science.1251827","article-title":"Two Decades After BRCA: Setting Paradigms in Personalized Cancer Care and Prevention","volume":"343","author":"Couch","year":"2014","journal-title":"Science"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.ajhg.2023.03.002","article-title":"Variants in ATRIP are associated with breast cancer susceptibility in the Polish population and UK Biobank","volume":"110","author":"Cybulski","year":"2023","journal-title":"Am. J. Hum. Genet."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e20241432","DOI":"10.1084\/jem.20241432","article-title":"Replication stress, microcephalic primordial dwarfism, and compromised immunity in ATRIP deficient patients","volume":"222","author":"Duthoo","year":"2025","journal-title":"J. Exp. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1038\/s41588-023-01466-z","article-title":"Exome sequencing identifies breast cancer susceptibility genes and defines the contribution of coding variants to breast cancer risk","volume":"55","author":"Wilcox","year":"2023","journal-title":"Nat. Genet."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/s41523-025-00826-8","article-title":"Meta-analysis of exome-wide gene burden analysis of breast cancer susceptibility genes","volume":"11","author":"Collister","year":"2025","journal-title":"Npj Breast Cancer"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"6930","DOI":"10.1093\/nar\/gkt467","article-title":"A novel interplay between the Fanconi anemia core complex and ATR-ATRIP kinase during DNA cross-link repair","volume":"41","author":"Tomida","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Beumer, J.H., Fu, K.Y., Anyang, B.N., Siegfried, J.M., and Bakkenist, C.J. (2015). Functional analyses of ATM, ATR and Fanconi anemia proteins in lung carcinoma: ATM, ATR and FA in lung carcinoma. BMC Cancer, 15.","DOI":"10.1186\/s12885-015-1649-3"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s13073-025-01499-5","article-title":"Understanding how gene-disease relationships can impact clinical utility: Adaptations and challenges in hereditary cancer testing","volume":"17","author":"Horton","year":"2025","journal-title":"Genome Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1093\/abbs\/gmw041","article-title":"Replication protein A and more: Single-stranded DNA-binding proteins in eukaryotic cells","volume":"48","author":"Liu","year":"2016","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1091\/mbc.e04-11-1006","article-title":"ATRIP Binding to Replication Protein A-Single-stranded DNA Promotes ATR\u2013ATRIP Localization but Is Dispensable for Chk1 Phosphorylation","volume":"16","author":"Ball","year":"2005","journal-title":"Mol. Biol. Cell"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Ogi, T., Walker, S., Stiff, T., Hobson, E., Limsirichaikul, S., Carpenter, G., Prescott, K., Suri, M., Byrd, P.J., and Matsuse, M. (2012). Identification of the First ATRIP\u2013Deficient Patient and Novel Mutations in ATR Define a Clinical Spectrum for ATR\u2013ATRIP Seckel Syndrome. PLoS Genet., 8.","DOI":"10.1371\/journal.pgen.1002945"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.ajhg.2012.01.007","article-title":"Germline Mutation in ATR in Autosomal- Dominant Oropharyngeal Cancer Syndrome","volume":"90","author":"Tanaka","year":"2012","journal-title":"Am. J. Hum. Genet."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1126\/science.1065521","article-title":"ATR and ATRIP: Partners in checkpoint signaling","volume":"294","author":"Cortez","year":"2001","journal-title":"Science"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/S0076-6879(05)09007-5","article-title":"Recruitment of ATR--ATRIP, Rad17, and 9--1--1 Complexes to DNA Damage","volume":"Volume 409","author":"Yang","year":"2006","journal-title":"Methods in Enzymology"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1158\/0008-5472.CAN-23-0628","article-title":"BRCAness, Homologous Recombination Deficiencies, and Synthetic Lethality","volume":"83","author":"Murai","year":"2023","journal-title":"Cancer Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/ncb1212","article-title":"The cell-cycle checkpoint kinase Chk1 is required for mammalian homologous recombination repair","volume":"7","author":"Hansen","year":"2005","journal-title":"Nat. Cell Biol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13045-020-00874-6","article-title":"Participation of the ATR\/CHK1 pathway in replicative stress targeted therapy of high-grade ovarian cancer","volume":"13","author":"Gralewska","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1038\/s41419-020-03090-9","article-title":"ATRIP protects progenitor cells against DNA damage in vivo","volume":"11","author":"Grigaravicius","year":"2020","journal-title":"Cell Death Dis."}],"container-title":["Current Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1718-7729\/32\/12\/711\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T09:16:50Z","timestamp":1765963010000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1718-7729\/32\/12\/711"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,17]]},"references-count":23,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["curroncol32120711"],"URL":"https:\/\/doi.org\/10.3390\/curroncol32120711","relation":{},"ISSN":["1718-7729"],"issn-type":[{"type":"electronic","value":"1718-7729"}],"subject":[],"published":{"date-parts":[[2025,12,17]]}}}